GENEVA--(BUSINESS WIRE)--Unilabs, one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services, announced further growth today, reporting that for the quarter ending 30 June 2015, revenue was €172.1m, compared to €153.5m in Q2 2014. The results show a significant and positive organic sales growth of 7.1% (CER†) leading to EBITDA growth vs Q2 2014 of 25.6%. This marks the 4th successive quarter of revenue growth, EBITDA growth and cost savings.
Help employers find you! Check out all the jobs and post your resume.
